Evidence map›Paper›PMID 36593771›Full record

ArticleComputer methods and programs in biomedicine update2023

Predicting the evolution of COVID-19 mortality risk: A Recurrent Neural Network approach.

Marta Villegas, Aitor Gonzalez-Agirre, Asier Gutiérrez-Fandiño, Jordi Armengol-Estapé, Casimiro Pio Carrino, David Pérez-Fernández, Felipe Soares, Pablo Serrano, Miguel Pedrera, Noelia García and 1 more

Open access · goldAbstract read
In one paragraph

Article in Computer methods and programs in biomedicine update, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Marta VillegasBarcelona Supercomputing Center, Jordi Girona 1-3 08034, Barcelona, Spain.
Aitor Gonzalez-AgirreBarcelona Supercomputing Center, Jordi Girona 1-3 08034, Barcelona, Spain.
Asier Gutiérrez-FandiñoBarcelona Supercomputing Center, Jordi Girona 1-3 08034, Barcelona, Spain.
Jordi Armengol-EstapéBarcelona Supercomputing Center, Jordi Girona 1-3 08034, Barcelona, Spain.
Casimiro Pio CarrinoBarcelona Supercomputing Center, Jordi Girona 1-3 08034, Barcelona, Spain.
David Pérez-FernándezSpanish Ministry of Inclusion, Social Security and Migration, Paseo de la Castellana 63 28071, Madrid, Spain.
Felipe SoaresUniversidade Federal do Rio Grande do Sul, Av. Osvaldo Aranha, 99, Porto Alegre, Brazil.
Pablo SerranoHospital Universitario 12 de Octubre, Av. de Córdoba s/n 28041, Madrid, Spain.
Miguel PedreraHospital Universitario 12 de Octubre, Av. de Córdoba s/n 28041, Madrid, Spain.
Noelia GarcíaHospital Universitario 12 de Octubre, Av. de Córdoba s/n 28041, Madrid, Spain.
Alfonso ValenciaBarcelona Supercomputing Center, Jordi Girona 1-3 08034, Barcelona, Spain.
Barcelona Supercomputing Center · ESHospital Universitario 12 De Octubre · ESUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In December 2020, the COVID-19 disease was confirmed in 1,665,775 patients and caused 45,784 deaths in Spain. At that time, health decision support systems were identified as crucial against the pandemic. Methods: This study applies Deep Learning techniques for mortality prediction of COVID-19 patients. Two datasets with clinical information were used. They included 2,307 and 3,870 COVID-19 infected patients admitted to two Spanish hospitals. Firstly, we built a sequence of temporal events gathering all the clinical information for each patient, comparing different data representation methods. Next, we used the sequences to train a Recurrent Neural Network (RNN) model with an attention mechanism exploring interpretability. We conducted an extensive hyperparameter search and cross-validation. Finally, we ensembled the resulting RNNs to enhance sensitivity. Results: We assessed the performance of our models by averaging the performance across all the days in the sequences. Additionally, we evaluated day-by-day predictions starting from both the hospital admission day and the outcome day. We compared our models with two strong baselines, Support Vector Classifier and Random Forest, and in all cases our models were superior. Furthermore, we implemented an ensemble model that substantially increased the system's sensitivity while producing more stable predictions. Conclusions: We have shown the feasibility of our approach to predicting the clinical outcome of patients. The result is an RNN-based model that can support decision-making in healthcare systems aiming at interpretability. The system is robust enough to deal with real-world data and can overcome the problems derived from the sparsity and heterogeneity of data.

Indexed as

COVID-19Mortality predictionRecurrent Neural NetworkTime series

Identifiers

PMID36593771
PMCPMC9798667
OpenAlexW4313489014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.